Puma biotechnologies 2025
Puma biotechnologies 2025
Puma biotechnologies 2025
Puma biotechnologies 2025
Puma biotechnologies 2025
Puma biotechnologies 2025

Puma biotechnologies 2025

Puma biotechnologies 2025, Puma Biotechnology Inc. LinkedIn 2025

$45.00

SKU: 7481089

Colour
  • Puma Biotechnology Receives FDA Orphan Drug Designation for Alisertib for the Treatment of Small Cell Lung Cancer PharmiWeb
  • Puma Biotechnology Biotechnology The Pharmaletter The Pharmaletter
  • Puma Biotechnology Announces Initiation of ALISCA Breast1 Phase II Trial of Alisertib in Hormone Receptor Positive HER2 Negative Metastatic Breast Cancer Business Wire
  • Puma Biotechnology Biotechnology The Pharmaletter The Pharmaletter
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus